Nanoparticle-mediated targeted drug delivery for breast cancer treatment

PY Liyanage, SD Hettiarachchi, Y Zhou, A Ouhtit… - … et Biophysica Acta (BBA …, 2019 - Elsevier
Breast cancer (BC) is the most common malignancy in women worldwide, and one of the
deadliest after lung cancer. Currently, standard methods for cancer therapy including BC are …

Nanotherapeutics for the Treatment of Cancer and Arthritis

P Patel, N Meghani, K Kansara… - Current drug …, 2019 - ingentaconnect.com
Background: Nanotechnology is gaining significant attention worldwide for the treatment of
complex diseases such as AIDS (acquired immune deficiency syndrome), cancer and …

Transfection with p21 and p53 tumor suppressor plasmids suppressed breast tumor growth in syngeneic mouse model

N Ibnat, NI Kamaruzman, M Ashaie, EH Chowdhury - Gene, 2019 - Elsevier
Abstract Treatment of breast cancer by delivering important tumor suppressor plasmids is a
promising approach in the field of clinical medicine. We transfected p21 and p53 tumor …

Yulangsan polysaccharide inhibits 4T1 breast cancer cell proliferation and induces apoptosis in vitro and in vivo

N Qin, S Lu, N Chen, C Chen, Q Xie, X Wei, F Ye… - International journal of …, 2019 - Elsevier
Yulangsan polysaccharide (YLSPS) is derived from the root of Millettia pulchra (Benth.) Kurz
var. Recent studies have postulated YLSPS as a regimen for cancer treatment. However, the …

[PDF][PDF] Is active targeting of brain metastases of breast cancer superior to passive targeting

NH Kamal, F El-Amrawy, HA Ali, I Edafiogho… - J Cancer Metastasis …, 2019 - f.oaes.cc
Brain metastasis is a major cause of death in patients with solid cancers. Breast cancer cells
have high tendency to migrate towards brain. Cancer cells within brain are characterized by …

Nanomedicine, a new therapeutic strategy in breast cancer treatment

A Taherian, N Esfandiari - Archives of Breast Cancer, 2019 - archbreastcancer.com
Background: As cancers, especially breast cancer, have become the most lethal and
concerning subject, new methods to promote therapies and achieve better results are …

Radiotherapy and breast cancer nanomedicine

M Anuje, J Bauer, ND Thorat - External Field and Radiation …, 2019 - iopscience.iop.org
In this chapter the field of radiation oncology is elaborated with emphasis on experienced
multiple technologic revolutions. With the advent of computers, of newer technological …

[PDF][PDF] Targeted Delivery of 5-FU-loaded Quantum Dots Based System into Cancer Induced Mice using Receptor-based Chemistry; Effect on Adaptive Immune …

IB Bwatanglang - adsujsr.adsu.edu.ng
Adequate understanding of the basic chemistry involved in the etiology of cancer has
unravelled the doggedness of cancer cells and paved ways for new strategies in cancer …

[PDF][PDF] Receptor Targeting Liposomal Nano Formulations for Drug Delivery in Breast Cancer

V Bakrol - scholar.archive.org
Recently, incidences of breast cancer are increasing and it has become a leading cause of
cancer related deaths of women globally. Though pharmaceutical and biotechnology …

[PDF][PDF] CD95R-Fc coated Microparticle Delivery to Cancer Cells

H Baldie - 2019 - qmro.qmul.ac.uk
Triple-negative breast cancers lack the three main breast cancer biomarkers; oestrogen-,
progesterone-or HER2-receptors and chemotherapy is the only established treatment option …